Mutated EGFR-IN-2 - CAS# 2050906-97-1 Size:Contact [email protected] for quotation 4-benzodiazepin-3-yl]-3-(3

4-benzodiazepin-3-yl]-3-(3

EC 690-730-1

A Review of Recent Patents on the Protozoan Parasite HSP90 as a Drug Target

RNA-binding protein necessary for virus replication

Formula: C33H31BO12

Mutated EGFR-IN-2 - CAS# 2050906-97-1 Size:Contact [email protected] for quotation 4-benzodiazepin-3-yl]-3-(3Mutated EGFR IN 2 (compound 91) is a mutant selective EGFR inhibitor extracted from patent WO2017036263A1, which potently inhibits single mutant EGFR (T790M) and double mutant EGFR (including L858R T790M (IC50=1nM) and ex19del T790M), and can suppress activity of single gain of function mutant EGFR (including L858R and ex19del) as well. Mutated EGFR IN 2 shows anti tumor antivity. Product information CAS Number: 2050906 97 1 Molecular Weight: 562. 64